Participated · Seed · Apr 2023

Xilva operates a platform for investments in regenerative forests, using a proprietary methodology called Xilva GRADE to assess and de-risk forest projects. The company conducts due diligence through the Xilva GRADE platform and provides certified carbon credits as well as investment opportunities for corporate buyers. Xilva has signed contracts facilitating over $1.9 million in transactions toward forestry projects in Asia and Latin America and has contributed to the compensation of more than 152,000 tons of CO2. Led by CEO Tim Duehrkoop, the company intends to use new funding to further develop its technological solutions and to scale marketing and operations. Xilva targets reducing investor risk related to carbon credits and nature restoration initiatives through its assessment methodology. The company is based in Zurich, Switzerland.

Participated · Series A · Jul 2021

Sweetch is an Israeli company that builds an AI-driven behavior-change app which analyzes smartphone “lifeprint” data to deliver hyper-personalized, emotionally intelligent reminders. The app times messages and modulates tone to increase the likelihood users follow clinical advice, and is distributed via partnerships with healthcare organizations, pharma, payers and providers rather than as an open app. Sweetch reports "tens of thousands of users" and about 45% of patients remain active after 24 months. In a 55-person prediabetes trial run at two Johns Hopkins Clinical Research Network sites, participants who completed the three-month study increased physical activity by an average of 2.8 MET-hours, lost ~1.6 kg, and reduced A1c by ~0.1%. The company has received NIH grant support to continue testing against gold-standard interventions and plans upcoming randomized controlled trials. Sweetch says it will use the Series A proceeds to expand into the U.S. and Brazil, grow its user base, and further tailor recommendations for additional conditions. Sweetch offers a patent-pending mobile app that assesses individuals' diabetes risk with a conversion time horizon and uses algorithms to guide users to the key objectives of the Diabetes Prevention Program. The product is intended for people at risk of developing diabetes or those who may be undiagnosed. Sweetch aligns its guidance with the clinically validated diet and exercise regimen associated with the Diabetes Prevention Program. The company planned to participate in a pilot study at Johns Hopkins Medicine in the first quarter of the year. The recent financing will support Sweetch's ambition to go to market in the U.S. and to be prescribed by doctors there, leveraging the Centers for Medicare and Medicaid decision to provide reimbursement for DPP participants. Leadership includes CEO Dana Chanan, CMO and business development lead Dr. Yossi Bahagon, and CTO Dan Lichtenfeld.

Led · Seed · Aug 2017

Sherpa is developing a yet-to-launch, artificial-intelligence–powered insurance platform that constructs a dynamic risk profile for each member and recommends or arranges coverage tailored to that individual. By removing the traditional product-centric approach, the company aims to insure people, not discrete policies, spanning categories such as home, health, life, travel, car, devices, and pets. Its technology continually refreshes each user’s risk assessment, alerting them to changing exposures and the associated cost of protection. Sherpa has partnered with reinsurance giant Gen Re and eliminates carrier commissions, passing those savings back to consumers. The founding team combines insurance veterans, data scientists, and technologists, led by former BCG insurance partner Chris Kaye. Although it has not yet launched commercially, the company has attracted outside capital to finalize product development and prepare for market entry. To date, Sherpa has raised a $2.3 million seed round, providing initial runway for product launch and early customer acquisition.